Four Japanese researchers published an analysis on cholesterol guidelines and statin drugs in the April 2015 edition of the Annals of Nutrition and Metabolism. Dr. Malcolm Kendrick, the Scottish doctor who wrote "The Great Cholesterol Con" recently stated on his blog that he has read the entire 116 page review: "For many years I have told anyone who will listen that, if you have a high cholesterol level, you will live longer. Equally, if you have a low cholesterol level, you will die younger. This, ladies and gentlemen, is a fact. The older you become the more beneficial it is to have a high cholesterol level. This fact has become more difficult to demonstrate recently as so many people have been put on statins that the association between cholesterol levels and mortality has been twisted, bent and pumelled into the weirdest shapes imaginable. However, Japan, provides some very interesting data."
Another study has confirmed that statin drug use increases one's chance of developing diabetes. Statin drugs are the all-time leading prescription drugs sold in the U.S. and around the world, prescribed by doctors to lower people's cholesterol levels. It is estimated that one out of every 4 people in the United States over the age of 50 is currently taking statin drugs for cholesterol. This current study just published looked at 26,000 beneficiaries of Tricare, the military health system. They found that those taking statin drugs to control their cholesterol were 87 percent more likely to develop diabetes. The study was published in the Journal of General Internal Medicine. This is just the latest study to link statin drugs to diabetes, especially in women. Studies published in 2014 caused over 2000 lawsuits to be filed against Pfizer, the maker of the best-selling drug of all-time, Lipitor.
My father was a cardiologist who started his practice in the 1970’s. In those days, the beauty and art of medicine were in the diagnosis of heart disease. They didn’t have many “tools” to treat patients. There were only a few pharmaceuticals and surgery was new on the scene. Fast forward to 2015. If you walk into a cardiology office you will walk out with a stack of prescriptions and orders for testing such as treadmills and ultrasounds. But what are the benefits?
Limitations for cholesterol will likely be removed from the 2015 edition of Dietary Guidelines for Americans; over consumption of dietary cholesterol is now cited as being of no concern. A recent review of studies investigating the link between dietary fat and causes of death concluded that recommendations to reduce the amount of fat we eat every day should never have been made. When fat was removed from processed foods, sugar was added in. This has led to a massive increase in obesity, diabetes, and non-alcoholic fatty liver disease, even among children
As reported in the New York Times (2.20.15), a nutrition advisory panel that shapes U.S dietary advice eased some of the previous restrictions on fat and cholesterol, while at the same time recommending Americans lower their consumption of sugar. For many years, I have been writing and lecturing about the idiotic cholesterol and fat guidelines that the Powers-That-Be have been espousing. Over 30 years ago, we were told to eat less fat and cholesterol in order to lower our risk from dying from cardiovascular disease. During that same time we were encouraged to increase our consumption of carbohydrates in the form of grains and bakery products. We followed the Powers-That-Be’s advice and guess what? Our health has worsened. During the time we lowered our fat and cholesterol intake, we suffered with more obesity, diabetes, and heart disease.
Statins work by poisoning an enzyme (HMG-CoA reductase) which is needed to produce cholesterol, adrenal and sex hormones, memory proteins and maintain cell energy. The highest concentration of cholesterol in the body is found in the brain. There were 36,605 reports of brain dysfunction from the FDA Adverse Events Databases which included memory impairment, transient cases of global amnesia, confusion, paranoia, disorientation, depression, and dementia related to statin use. Remember, this number is thought to represent only 1-10% of the true number of adverse drug reactions.
Why should a 2% cardiovascular risk reduction in a drug that has shown nothing before this be considered a success? And, keep in mind, that this risk reduction did not include the most meaningful risk reduction–death. This study found no difference in the most important endpoints: overall deaths, cardiovascular deaths, or coronary deaths. Why does my profession accept this mediocrity? Not only do they accept it, they embrace it. It is pathetic. Folks, we spend too much money on drugs that provide little, if any, benefit. In fact, we spend more on drugs than any country on the face of the earth and we lag behind every major Western country on every important health and disease indicator. This study should be the last nail in the coffin for Vytorin. It is a failed drug that has little usefulness. We would be better served to remove it from the marketplace.
Here is a fact that has been known for quite a long time, but it is still news to many people: People with higher cholesterol levels live longer than people with lower cholesterol levels. The reason why this fact is not well-known in the general public is because it would put a huge dent into a $100 BILLION drug market for statin drugs - drugs that lower your cholesterol. With approximately one out of every 4 Americans over the age of 50 currently prescribed a statin drug, a drug with very serious side effects, this is certainly one issue you should investigate yourself.
Lawsuits filed against Pfizer for their blockbuster cholesterol-lowering drug Lipitor reached 1162 cases filed in August. Almost all of theses cases have been filed since April, when a new study was released linking Type 2 diabetes in women with the popular statin drug. Attorneys filing claims for the victims have stated the cases could well reach 10,000. Cholesterol-lowering statin drugs are a $100 billion a year industry. Lipitor is by far the most profitable drug in the history of mankind among all pharmaceutical products, let alone being the most profitable cholesterol drug before its patent expired at the end of 2011. Sales to date from this one particular cholesterol-lowering statin drug have exceeded $140 billion. Lipitor benefited from the change in marketing laws in 1997 that allowed pharmaceutical companies in the U.S. to advertise their products directly to consumers. Pfizer convinced an entire generation of Americans that they needed a pill to lower their cholesterol in order to prevent heart disease, in what will go down as one of the most brilliant and unethical marketing schemes of all time. After Lipitor’s patent expired at the end of 2011, the FDA issued its first warnings against statin drugs, which includes: liver injury, memory loss, diabetes, and muscle damage. Soon after issuing these warnings, the lawsuits started trickling in. Today, with more and more studies being published linking statin drug use to various side effects, those lawsuits have become a tidal wave, even though you are not likely to hear much about this in the mainstream media.
A study recently published in the international journal Drug Safety found a positive association between regular statin drug use and Bell's palsy, a neurologic disorder. This study confirms what Dr. Stephanie Seneff published back in 2009, showing how stain drugs used to lower cholesterol could be a main cause of Alzheimer's and other neurological diseases in old age.